Elite Pharma Alpha and Beta Analysis
| ELTPDelisted Stock | USD 0.04 0 6.75% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Elite Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Elite Pharma over a specified time horizon. Remember, high Elite Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Elite Pharma's market risk premium analysis include:
Beta (0.58) | Alpha 0.96 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Elite |
Elite Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Elite Pharma market risk premium is the additional return an investor will receive from holding Elite Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Elite Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Elite Pharma's performance over market.| α | 0.96 | β | -0.58 |
Elite Pharma Fundamentals Vs Peers
Comparing Elite Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elite Pharma's direct or indirect competition across all of the common fundamentals between Elite Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elite Pharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elite Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Elite Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elite Pharma to competition |
| Fundamentals | Elite Pharma | Peer Average |
| Return On Equity | 0.27 | -0.31 |
| Return On Asset | 0.0739 | -0.14 |
| Profit Margin | 0.20 % | (1.27) % |
| Operating Margin | 0.15 % | (5.51) % |
| Current Valuation | 27.92 M | 16.62 B |
| Shares Outstanding | 1.01 B | 571.82 M |
| Shares Owned By Insiders | 17.53 % | 10.09 % |
Elite Pharma Opportunities
Elite Pharma Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Elite Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Elite or other otcs. Alpha measures the amount that position in Elite Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Elite Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Elite Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elite Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Elite Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Elite Pharma. Please utilize our Beneish M Score to check the likelihood of Elite Pharma's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Elite Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |